Blocking Tie2 activation in a collagen induced arthritis model inhibits arthritis-induced angiogenesis, RANKL expression leading to a reduction in bone erosion suggesting Tie2 as a potential therapeutic target [52], [53]. This evidence concerns the gene TNFSF11 and arthritic joint disease.